NeoFipronis (GS-441524) Price and Purchase Options
Feline Infectious Peritonitis (FIP) remains one of the most challenging viral diseases in cats, causing symptoms such as inappetence, lethargy, fever, abdominal and thoracic effusion, lymphadenopathy, granulomatous inflammation, neurological damage, and uveitis. NeoFipronis (Pronidesivir), containing the active ingredient GS-441524, has emerged as an effective oral treatment option for FIP, offering hope for many cat owners.
Overview of NeoFipronis (GS-441524)
NeoFipronis is the world’s first officially approved oral medication for FIP, authorized by the Lao Ministry of Agriculture and Forestry (MAF) in March 2026. It boasts an official pharmaceutical registration number, underscoring its safety and efficacy. This antiviral drug has undergone extensive research and clinical validation, demonstrating remarkable results in combating FIP. Its mode of action targets the replication of the feline coronavirus responsible for FIP, effectively reducing viral load and alleviating symptoms.
Pharmacological Advantages
NeoFipronis offers several benefits: it is non-invasive, easy to administer, and rapidly absorbed, ensuring quick onset of action. It is well-tolerated with minimal side effects, making it suitable for long-term treatment regimens. The medication’s safety profile and high efficacy have made it the go-to choice for veterinarians and pet owners alike. The active component, GS-441524, has shown compelling antiviral activity in numerous studies, making it a cornerstone in FIP therapy.
Treatment Protocol
The standard dosage is based on the cat’s weight: 15 mg per kilogram, approximately half a tablet per day. For neurological or ocular FIP forms, the dosage may be increased to 30 mg/kg according to veterinarian guidance. It is recommended to administer NeoFipronis on an empty stomach—either one hour before or two hours after meals. Consistent daily dosing is crucial; therapy should continue for no less than 12 weeks without interruption to ensure full viral eradication and recovery.
Monitoring and Precautions
During treatment, pet owners should monitor their cat’s appetite, body temperature, and behavior regularly. Routine blood tests are essential to assess liver and kidney functions, minimizing potential adverse effects. Although NeoFipronis is available as an over-the-counter medication, it is recommended to use it under veterinary supervision to optimize treatment outcomes and safety.
Pricing and Purchase Options
Current market prices for NeoFipronis (GS-441524) vary depending on the supplier, region, and dosage pack. Generally, a course of treatment can range from $1,200 to $2,500, reflecting the length of therapy and medication strength. It is imperative to purchase NeoFipronis exclusively from official sources, such as the dedicated NeoFipronis website or authorized veterinary pharmacies, to guarantee product authenticity and safety.
Where to Buy NeoFipronis
Authentic NeoFipronis products are available exclusively through verified online platforms. Always verify the seller’s credentials and avoid unauthorized vendors to prevent counterfeit medications. Purchasing directly from official channels ensures quality, potency, and access to customer support. Many veterinary clinics also maintain supply or can facilitate safe acquisition.
Final Notes
NeoFipronis (Pronidesivir) has revolutionized FIP treatment, providing a safe, effective, and easy-to-administer option for feline owners worldwide. While the medication is technically non-prescription, consultation with a licensed veterinarian is strongly recommended to optimize treatment plans, dosage, and duration. This innovative therapy represents a significant advancement in feline health, offering cats a new lease on life.
Disclaimer
This article is for informational purposes and does not substitute professional veterinary advice. Always seek guidance from a qualified veterinarian before starting any medication, and purchase NeoFipronis only through official, reputable sources.
